“…17 This could potentially lead to the development of new drugs that could target both hypertension and the metabolic syndrome. 18 Also, Guizar-Mendoza et al 19 performed a study to establish the relationship between Gln223Arg polymorphism in the human leptin receptor gene (LEPR) and traits related to obesity in Mexican adolescents. Their study showed that obese adolescents have higher heart sympathetic activity, blood pressure, insulin and leptin levels than non-obese subjects, and furthermore those who were carriers of the Gln223Arg polymorphism of LEPR have sympathetic overactivity and hypertension.…”